Delivery Order SPE2DB22D1106-SPE2DB25FEZH3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Diovan HCT 80-12.5 mg tablets (90-count) valued at $8,201.10. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's broader...
- The Defense Logistics Agency awarded a delivery order valued at $6,096.46 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Diovan HCT 320-12.5 mg tablets (90-count units). The contract represents a firm fixed price, non-set-aside procurement with an ultimate completion date of July 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,931.27 firm fixed-price delivery order is for the supply of Diovan HCT 160-12.5 mg tablets. The contract has an ultimate completion date of June 4, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00. This prime contract,...
- The Defense Logistics Agency awarded a delivery order valued at $2,212.91 to AmerisourceBergen Drug Corp for 90 tablets of Diovan HCT 320-12.5 mg, a combination antihypertensive medication. The contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, utilizing firm fixed pricing with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Diovan HCT 320-12.5 mg tablets (90-count) with a firm fixed price ceiling value of $1,746.64. This non-set-aside, competitively awarded contract is scheduled for ultimate completion on July 22, 2025, with performance taking place at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's critical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,698.54 contract is for the supply of Diovan HCT 160-12.5 mg tablets, a pharmaceutical product, with a performance period through March 15, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Diovan HCT 320-12.5 mg tablets (90-count) with a ceiling value of $3,437.75. This competitively awarded, firm fixed-price delivery order was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,904.49 firm-fixed-price contract is for the delivery of Diovan HCT 80-12.5 mg tablets. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Diovan HCT 160-25 mg tablets. The contract has a ceiling value of $1,335.14 and a period of performance through April 11, 2024. This delivery order is placed under an existing Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Diovan HCT 320-12.5 MG tablets. The $21,935.07 contract has an ultimate completion date of April 11, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for providing pharmaceuticals...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZH3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $97,006.28 to AmerisourceBergen Drug Corp for the supply of Diovan HCT 160-25 mg tablets (90-count) under a firm fixed price contract. The award, issued on July 23, 2025, with completion by July 24, 2025, represents a competitive procurement with no set-aside designation. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a critical position in the federal medical supply chain, particularly supporting military and veteran healthcare systems. As a prime contractor under the DLA's pharmaceutical procurement framework, the company supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The Diovan HCT delivery order exemplifies the company's role in supporting Defense Health Agency requirements and broader government healthcare systems through flexible contract vehicles designed to serve military medical needs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $97.0k | 7/23/25 |